Roperch et al., [44] observed that NPY, proenkephalin (PENK), and Wnt inhibitory factor 1 (WIF1) can be used as combined epigenetic markers for the diagnosis of CRC, both in tissue and serum. This evidence concerns the gene WIF1 and colorectal carcinoma.